BACKGROUND: Both unfractionated heparin (UFH) and low-molecular-weight heparin (LMWH) are approved for venous thromboembolism (VTE) prophylaxis. Which agent is superior remains controversial.

Unless a specific contraindication exists, professional guidelines recommend LMWH and DOACs over UFH for the majority of patients hospitalized for acute PE who are treated with parenteral ...